Non-Current Assets
Indefinite-Lived Research and Development Assets
International Business Machines Indefinite-Lived Research and Development Assets increased by 5.8% to $4.43B in Q4 2025 compared to the prior quarter. Over 3 years (FY 2022 to FY 2025), Indefinite-Lived Research and Development Assets shows an upward trend with a 13.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2022
Last reportedQ4 2025Feb 24, 2026
How to read this metric
An increase indicates active investment in future technology, while a decrease may signal project completion or impairment.
Detailed definition
These are acquired in-process research and development (IPR&D) projects that have not yet reached technological feasibil...
Peer comparison
Common in technology and pharmaceutical sectors following M&A activity.
Metric ID:
indefinite_lived_rd_assetsHistorical Data
4 periods
| Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|
| Value | $3.01B | $3.52B | $4.19B | $4.43B |
| QoQ Change | — | +17.0% | +18.8% | +5.8% |
| YoY Change | — | +17.0% | +18.8% | +5.8% |
Range$3.01B – $4.43B
Avg YoY Growth+13.8%
Median YoY Growth+17.0%
Current Streak3+ quarters growth
Indefinite-Lived Research and Development Assets at Other Companies
Frequently Asked Questions
- What is International Business Machines's indefinite-lived research and development assets?
- International Business Machines (IBM) reported indefinite-lived research and development assets of $4.43B in Q4 2025.
- What is the long-term trend for International Business Machines's indefinite-lived research and development assets?
- Over 3 years (2022 to 2025), International Business Machines's indefinite-lived research and development assets has grown at a 13.7% compound annual growth rate (CAGR), from $3.01B to $4.43B.
- What does indefinite-lived research and development assets mean?
- The value of research projects acquired from other companies that are still in progress.